GOVERNANCE ADVISORY AS
Operating
Analyser, utredninger, betenkninger, evalueringer, anbefalinger,
foredrag, kurs og lignende samt virksomhet som naturlig hører til
dette, særlig innen personvern og bioetikk, ofte relatert til helse,
persontilpasset medisin, bioteknologi, livsvitenskap, biobanker,
kunstig intelligens og/eller medisinsk teknologi. Evaluering av og
rådgivning til forskningsprosjekter, herunder også møter og uavhengig
rapportering. Samarbeid med eller deltakelse i andre selskaper med
lignende aktivitet og/eller som utfyller selskapets egen virksomhet.
Organization
- CEO
- HB
- Chairman of the board
- HB
- Years since formation
- 6 years
- since Nov 6, 2020
- Type
- Limited company
- VAT registered
- Yes
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 30
- 1 share class
- Total number of shareholders
- 1
- person
Financials
- Total operating income 2025
- 499,385
- NOK
- Annual total result 2025
- -8,117
- NOK
- Total equity 2025
- 14,466
- NOK
Last update: Jan 27, 2026
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
HB | Managing Director/CEO | 100 % directly |
Board
| Name | Role | Shares |
|---|---|---|
HB | Chairman | 100 % directly |
Others
| Name | Role | Shares |
|---|---|---|
| Accountant | - |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
HB | Managing Director/CEO, Chairman | 100 % directly |
Last update: Apr 13, 2023
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
HB | Ordinary shares | 30 | 100 % |
Last update: Sep 25, 2026
Financials
in NOK
Summary
| Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
Total operating income | 499,385 | 265,788 | 391,293 | 265,956 |
Annual Total Result | -8,117 | -38,766 | 44,066 | -15,697 |
Total assets | 113,353 | 83,704 | 153,665 | 71,859 |
Total liabilities | 98,886 | 61,121 | 92,316 | 54,577 |
Total equity | 14,466 | 22,583 | 61,349 | 17,282 |
P&L
| Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
Total operating income | 499,385 | 265,788 | 391,293 | 265,956 |
Total operating costs | 519,162 | 304,099 | 340,173 | 280,694 |
Operating result | -19,777 | -38,311 | 51,120 | -14,738 |
Financial income/costs | -1,512 | -455 | 639 | -959 |
Profit before tax | -21,289 | -38,766 | 51,759 | -15,697 |
Total tax & extraordinary income/cost | -13,172 | 0 | 7,693 | 0 |
Annual Total Result | -8,117 | -38,766 | 44,066 | -15,697 |
Balance overview
| Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
Total fixed assets | 13,173 | 0 | 0 | 0 |
Total current assets | 100,180 | 83,704 | 153,665 | 71,859 |
Total assets | 113,353 | 83,704 | 153,665 | 71,859 |
Short term debt | 98,886 | 61,121 | 92,316 | 54,577 |
Long term debt | 0 | 0 | 0 | 0 |
Total liabilities | 98,886 | 61,121 | 92,316 | 54,577 |
Contributed capital | 30,000 | 30,000 | 30,000 | 30,000 |
Retained earnings | -15,534 | -7,417 | 31,349 | -12,718 |
Total equity | 14,466 | 22,583 | 61,349 | 17,282 |
Total equity and liabilities | 113,353 | 83,704 | 153,665 | 71,859 |
Classification
21st company classification
BETA
Small company
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification